Related Experiment Video
Updated: Jun 1, 2026
06:32
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
BMP4 promotes prostate tumor growth in bone through osteogenesis
Yu-Chen Lee1, Chien-Jui Cheng, Mehmet A Bilen
1Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, USA.
Cancer Research
|June 15, 2011
Summary
Prostate cancer bone lesions often form new bone. This study reveals bone morphogenetic protein 4 (BMP4) drives osteogenesis, promoting prostate tumor growth in bone via BMP4-mediated pathways.
Area of Science:
- Oncology
- Orthopedics
- Molecular Biology
Background:
- Prostate cancer frequently metastasizes to bone, inducing new bone formation.
- The necessity of osteogenesis for prostate tumor progression in bone remains unclear.
- Two xenografts, MDA-PCa-118b and MDA-PCa-133, were developed from prostate cancer bone metastases to study this phenomenon.
Purpose of the Study:
- To investigate the role of osteogenesis in prostate cancer bone metastasis.
- To identify key factors involved in tumor-induced bone formation.
- To determine if targeting osteogenesis can inhibit prostate cancer growth in bone.
Main Methods:
- Comparison of secretomes from osteogenic (MDA-PCa-118b) and non-osteogenic (MDA-PCa-133) xenografts using cytokine arrays.
- Assessment of bone morphogenetic protein 4 (BMP4) contribution to osteogenic differentiation using neutralizing antibodies and small molecule inhibitors (LDN-193189).
- Evaluation of tumor growth in severe combined immunodeficient (SCID) mice treated with LDN-193189.
Main Results:
- MDA-PCa-118b xenografts exhibited higher expression of BMP4 and related cytokines compared to MDA-PCa-133.
- Secreted BMP4 from MDA-PCa-118b contributed significantly to osteogenic differentiation.
- Inhibition of BMP4 signaling pathways reduced osteoblast differentiation and significantly inhibited tumor growth in vivo.
- MDA-PCa-118b cells showed low BMP receptor expression, suggesting a paracrine mechanism for BMP4 action.
Conclusions:
- Bone morphogenetic protein 4 (BMP4) plays a crucial role in mediating osteogenesis in prostate cancer bone metastases.
- BMP4-driven osteogenesis supports prostate cancer progression in the bone microenvironment.
- Targeting BMP4 signaling represents a potential therapeutic strategy for prostate cancer bone disease.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...